Gupta et al., 2005 - Google Patents
Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptidesGupta et al., 2005
- Document ID
- 7236217696636034941
- Author
- Gupta B
- Levchenko T
- Torchilin V
- Publication year
- Publication venue
- Advanced drug delivery reviews
External Links
Snippet
Cell-penetrating peptides (CPPs) have been used to overcome the lipophilic barrier of the cellular membranes and deliver large molecules and even small particles inside the cell for their biological actions. CPPs are being used to deliver inside cell a large variety of cargoes …
- 102000004169 proteins and genes 0 title abstract description 76
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
- A61K47/48246—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gupta et al. | Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides | |
| Wagstaff et al. | Protein transduction: cell penetrating peptides and their therapeutic applications | |
| Järver et al. | Cell-penetrating peptides—a brief introduction | |
| Pujals et al. | Proline-rich, amphipathic cell-penetrating peptides | |
| Wadia et al. | Protein transduction technology | |
| Vives | Present and future of cell-penetrating peptide mediated delivery systems:“is the Trojan horse too wild to go only to Troy?” | |
| Kardani et al. | Cell penetrating peptides: the potent multi-cargo intracellular carriers | |
| Kerkis et al. | Properties of cell penetrating peptides (CPPs) | |
| Futaki | Membrane-permeable arginine-rich peptides and the translocation mechanisms | |
| Tung et al. | Arginine containing peptides as delivery vectors | |
| El-Andaloussi et al. | Cell-penetrating peptides: mechanisms and applications | |
| Patel et al. | Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives | |
| Lindgren et al. | Classes and prediction of cell-penetrating peptides | |
| Tréhin et al. | Chances and pitfalls of cell penetrating peptides for cellular drug delivery | |
| Fischer | Cellular uptake mechanisms and potential therapeutic utility of peptidic cell delivery vectors: progress 2001–2006 | |
| Temsamani et al. | The use of cell-penetrating peptides for drug delivery | |
| Fischer et al. | Cellular delivery of impermeable effector molecules in the form of conjugates with peptides capable of mediating membrane translocation | |
| Shin et al. | Cell‐penetrating peptides: Achievements and challenges in application for cancer treatment | |
| Nakase et al. | Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides | |
| Schwartz et al. | Peptide-mediated cellular delivery. | |
| Torchilin | Recent approaches to intracellular delivery of drugs and DNA and organelle targeting | |
| Torchilin | Intracellular delivery of protein and peptide therapeutics | |
| Kim et al. | Cytoplasmic transduction peptide (CTP): new approach for the delivery of biomolecules into cytoplasm in vitro and in vivo | |
| Park et al. | A protein delivery system using 30Kc19 cell-penetrating protein originating from silkworm | |
| US20060222657A1 (en) | Polypeptide transduction and fusogenic peptides |